Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: a case series and literature review

Combination of venetoclax with CHG regimen in refractory/relapsed T-lymphoblastic lymphoma/acute lymphoblastic leukemia: a case series and literature review

Abstract T lymphoblastic lymphoma/acute lymphoblastic leukemia (T-LBL/ALL) is a highly aggressive hematologic malignancy, with particularly poor outcomes for refractory/relapsed (R/R) patients. This article reports the efficacy and safety of V-CHG regimen (Venetoclax, cytarabine, homoharringtonine,...

Full description

Saved in:
Bibliographic Details
Main Authors: Mei Zhou, Yuze Yang, Xiaoyan Zhang, Yijie Jiao, Zhenxing Guo
Format: Article
Language:English
Published: Springer 2025-07-01
Series:Discover Oncology
Subjects:
T lymphoblastic lymphoma/T acute lymphoblastic leukemia
Venetoclax
Homoharringtonine
CHG regimen
Refractory/relapsed
Online Access:https://doi.org/10.1007/s12672-025-03055-4
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1007/s12672-025-03055-4

Similar Items